Navesta Pharmaceuticals (Pvt) Ltd.

Overview

Pharmaceutical manufacturing site surfaced via EU GMP non-compliance screening (EudraGMDP).

API / Drug Master Files

Navesta Pharmaceuticals (Pvt) Ltd. holds 3 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • POVIDONE-IODINE USPActive2019-04-02
  • VIGABATRINActive2018-09-22
  • OXYTOCINActive2012-09-22
  • OCTREOTIDE ACETATEInactive2012-06-13

FDA compliance signals

1 FDA enforcement record linked to this company.

  • eu_noncompliance2026-05-11

    EU GMP Statement of Non-Compliance

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.